News

Transcend plans for acquiring DTS by the merger of DTS and a subsidiary of Transcend. The acquisition is expected to be of $7.9m in cash, plus an earn-out

Banzel has been approved for the adjunctive treatment of seizures linked with Lennox-Gastaut syndrome (LGS) in children 4 years and older and adults. Eisai claims that its Banzel

Under the pact, both the companies will focus on developing RFID technologies for various areas where secure & reliable identification is a key requirement. Steria and Neology claim

OraSure Technologies’ Intercept Drug Testing System is the FDA-cleared in vitro diagnostic laboratory-based oral fluid testing system used for detecting commonly abused drugs such as marijuana, cocaine, opiates,

Reportedly, the Phase 3 Telatinib trial will compare Telatinib in conjunction with a standard regimen of chemotherapy versus chemotherapy alone in advanced stomach cancer patients. ACT Biotech said

Derrington brings a wealth of international operational and industry leadership, experience, and specific knowledge for maximizing operational performance, business development, and strategic partnerships. Recently, Derrington was chairman and

The tie up will enable TransUnion customers to access RemitDATA’s TITAN, an SaaS-based reimbursement and utilization platform. Upon implementation, TransUnion customers can also receive proactive, custom benchmarking notifications

The tie up is expected to capitalize on the extensive phytochemical and botanical reference standard capabilities of ChromaDex and will initially focus on the near infrared spectrometer (NIR)

In a recent animal study where GS 9219’s intravenous version was examined for the treatment of canine lymphoma, GS 9219 demonstrated significant activity against spontaneous non-Hodgkin’s lymphoma in